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This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based 
research. The summary is not intended to be a comprehensive summary of available evidence on 
COVID-19 but aims to make original documents easily accessible to decision makers which, if 
relevant to them, they should go to before making decisions. 
Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
21.08.2020 COVID-19 
associated 
hyperinflammation 
and escalation of 
patient care: a 
retrospective 
longitudinal cohort 
study 
The Lancet 
Rheumatology 
| Article 
 
• A retrospective 
cohort study in the 
UK but maybe 
useful in trial 
design 
• Associations 
between elevated 
inflammatory 
markers, 
escalation of 
respiratory 
support and 
survival in people 
with C19 indicate 
the existence of a 
high-risk 
inflammatory 
phenotype (COV-
HI) 
hyperinflammation 
 
  
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.08.2020 A 
vulnerability 
index for 
COVID-19: 
spatial 
analysis at 
the 
subnational 
level in 
Kenya 
BMJ Global 
Health | 
Original 
research  
• 3 vulnerability indices were 
created to identify the most 
vulnerable and their 
geographical location to 
inform the emergency 
response in Kenya 
• The heterogeneity of the 
vulnerability indices 
highlight the need for 
targeted and prioritised 
actions based on the needs 
across the subcounties 
• The vulnerability indices 
created are tools relevant 
to te county, national 
government and 
stakeholders for planning 
and prioritisation 
Vulnerability 
indices 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
26.08.2020 Rapid, point-
of-care 
antigen and 
molecular-
based tests 
for diagnosis 
of SARS-
CoV-2 
infection 
Cochrane 
Systematic 
Review - 
Diagnostic 
• This SR assesses the 
diagnostic accuracy of point-
of-care antigen and 
molecular-based tests to 
detect current SARS-CoV-2 
infection (with the aim of 
reducing household and 
community transmission) 
• This review identifies early-
stage POC tests for 
detecting SARS-CoV-2 
infection but largely based on 
remnant lab samples with 
uncertainty on whether the 
tests will perform in the same 
way in clinical practice 
• Rapid tests have the 
potential to be used to inform 
triage of RT-PCR use, 
allowing earlier detection of 
those testing positive, but the 
evidence currently is not 
strong enough to determine 
Point-of-
care tests 
how useful they are in clinical 
practice 
 21.08.2020 The 
interpretation 
of SARS-
CoV-2 
diagnostic 
tests 
 Cell | Review 
• Testing is a tool to manage 
the ongoing C19 pandemic 
and is widely used but test 
interpretation is incompletely 
understood creating a 
challenge in decision making 
and proper testing utilisation 
• Here general principles of 
test interpretation are 
reviewed and applied to 
specific examples 
• The review runs contrary to 
many popular narratives 
about testing as a tool for 
C19 
• Improper utilisation can 
potentially have unintended 
negative consequences 
 testing 
19.08.2020  Information 
given by 
website 
selling home 
self-sampling 
COVID-19 
tests: an 
analysis of 
accuracy and 
completeness 
 
medRxiv | 
preprint (not 
peer 
reviewed) 
 
• Cross-sectional 
observational study of 27 
websites selling direct to 
user home self-sampling and 
testing for C19 in the UK and 
US but included to highlight 
caution for online sales due 
to incomplete, and in some 
cases misleading information 
on test accuracy, intended 
use and test interpretation. 
• Best practice guidance for 
communication about tests to 
the public should be 
developed and enforced for 
online sales of C19 tests 
Online 
test sales 
Therapeutics 
Publication 
date 
Title/URL Journal/Article 
type 
Summary             Keywords 
21.08.2020 Effect of remdesivir 
vs standard care 
on clinical status at 
11 days in patients 
with moderate 
COVID-19: a 
randomized clinical 
trial 
JAMA | 
Original 
investigation 
 
• Randomised, open-
label, phase 3 trial 
that included 584 
patients with 
moderate C19  
• Hospitalised 
patients with 
moderate C19 
randomised to a 5 
day course of 
remdesivir had a 
remdesivir 
statistically 
significant better 
clinical status 
compared with 
those randomised 
to standard care at 
11 days after 
initiation of 
treatment, but the 
difference was of 
uncertain clinical 
importance 
21.08.2020 
 
Risk of 
hydroxychloroquine 
alone and in 
combination with 
azithromycin in the 
treatment of 
rheumatoid 
arthritis: a 
multinational, 
retrospective study 
The Lancet 
Rheumatology 
| Article 
 
• Hydroxychloroquine 
treatment appears 
to have no 
increased risk in 
the short term 
among patients 
with RA 
• In the long term 
though it appears 
to be associated 
with excess 
cardiovascular 
mortality 
• Addition of 
azithromycin 
increases the risk 
of heart failure and 
cardiovascular 
mortality even in 
the short term 
• Careful 
consideration must 
be given to the 
benefit-risk trade-
off when 
counselling those 
on 
hydroxychloroquine 
treatment 
Hydroxychloroquine, 
azithromycin, 
rheumatoid arthritis 
 
  
Indirect impact of COVID-19 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
25.08.2020 Immediate 
impact of stay-
at-home 
orders con 
control 
COVID-19 
transmission 
on 
socioeconomic 
conditions, 
food 
insecurity, 
mental health, 
and intimate 
partner 
violence in 
Bangladeshi 
women and 
their families: 
an interrupted 
time series 
The Lancet 
Global Health 
| Article 
• An interrupted time 
series to determine 
the immediate 
impact of C19 
lockdown orders on 
women and their 
families in rural 
Bangladesh on 
income, food 
security and mental 
health compared to 
a median on 1 year 
and 2 years before 
the C19 pandemic 
and also 
assessment of 
women’s IPV during 
the pandemic 
• There was marked 
reductions in 
income, increases in 
food insecurity, 
deteriorations in 
mental health and 
an increase in 
anxiety, and 
documents 
experiences of IPV 
• C19 lockdowns to 
reduce transmission 
of C19 exert 
substantial 
economic and social 
consequences to 
family welfare, family 
nutritional status, 
and to women’s 
mental wellbeing 
and safety  
• Should future 
lockdowns be 
required to control 
the transmission of 
an infectious 
disease, a 
comprehensive 
public health 
response must 
underwrite economic 
Lockdown, 
socioeconomic, 
food insecurity, 
mental health, 
IPV 
circumstances and 
include solutions to 
ensure the wellbeing 
of families and 
especially women 
20.08.2020 Impact of the 
societal 
response to 
COVID-19 on 
access to 
healthcare for 
non-COVID-19 
health issues 
in slum 
communities 
of Bangladesh, 
Kenya, Nigeria 
and Pakistan: 
results of pre-
COVID and 
COVID-19 
lockdown 
stakeholder 
engagements 
BMJ Global 
Health | 
Original 
research 
• Considers access to 
healthcare before 
and during COVID-
19 with those 
working and living in 
slum communities 
• With C19, a 
reduction in access 
to healthcare 
services was 
reported in all sites, 
including preventive 
services, costs of 
healthcare increased 
while household 
income reduced. 
Residents had 
difficulty reaching 
healthcare facilities. 
Fear of C19 
diagnosis 
discouraged 
healthcare seeking.  
• Alleviators such as 
provision of 
healthcare by phone 
were inconsistent 
and inadequate 
• Slum residents’ 
ability to seek 
healthcare for non-
C19 conditions has 
been reduced during 
lockdowns 
• Clear 
communications is 
needed about what 
is available and 
whether infection 
control is in place 
• Policymakers need 
to ensure that costs 
do not escalate and 
unfairly 
disadvantage slum 
communities  
Healthcare 
access, slums 
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type 
Sept 2020 Air travel in the time of COVID-19 The Lancet Infectious Diseases | 
Editorial 
Sept 2020 Transparency during global health 
emergencies 
The Lancet Digital Health | 
Editorial 
Sept 2020 COVID-19 and the communication blackouts 
in Kashmir, India 
The Lancet Psychiatry | 
Correspondence 
26.08.2020 A call for strengthened evidence on targeted, 
non-pharmaceutical interventions against 
COVID-19 for the protection of vulnerable 
individuals in sub-Saharan Africa 
International JID | Perspective 
25.08.2020 The COVID-19 multi-model comparison 
collaboration releases its first two outputs 
CGD | Blog 
25.08.2020 Africa Centres for Disease Control and 
Prevention’s COVID-19 response: A united, 
continental strategy 
World Bank | blog 
24.08.2020 Tuberculosis control and care in the era of 
COVID-19 
Health Policy and Planning | 
Commentary 
24.08.2020 Research, innovation vital in new COVID-19 
world 
SciDevNet| Opinion Peter Piot 
24.08.2020 Vaccines targeting SARS-CoV-2 tested in 
humans  
Nature Medicine | News & Views 
24.08.2020 Lifting the mask on neurological 
manifestations of COVID-19 
Nature Reviews Neurology | 
Perspective 
24.08.2020 COVID-19 care in India: the course to self-
reliance 
The Lancet Global Health | 
Comment  
24.08.2020 First Covid-19 reinfection documented in 
Hong Kong, researchers say 
 
Statnews (including a news 
article as the full research paper 
has not yet been published). 
Note only one case. 
23.08.2020 COVID-19 as social disability: the 
opportunity of social empathy for 
empowerment 
BMJ Global Health | 
Commentary 
23.08.2020 
 
Coronavirus: Trump authorizes plasma 
treatment amid attacks on FDA 
 
The Guardian | news  (included 
to highlight what is happening in 
the absence of unproven 
treatments) 
23.08.2020 The NIMH global mental health research 
community and COVID-19 
The Lancet Psychiatry | 
Comment 
21.08.2020 Multisystem inflammatory syndrome in 
children in South Africa 
The Lancet Child & Adolescent 
Health | Correspondence 
21.08.2020 Delving beneath the surface of 
hyperinflammation in COVID-19 
The Lancet Rheumatology | 
Comment 
21.08.2020 Efficacy of remdesivir in COVID-19 JAMA | Editorial 
21.08.2020 Coronavirus research updates: vaccines 
given through the nose could protect against 
infection 
Nature | News 
 
20.08.2020 Killer #2: Disrupted health services during 
COVID-19 
World Bank | blog 
20.08.2020 Bringing a COVID-19 vaccine to market: 
Where do we go from here? 
CGD | Blog 
20.08.2020 Global health and human rights for a 
postpandemic world 
BMJ Global Health | Editorial 
20.08.2020 How close are we to a vaccine for COVID-
19? 
BBC News World Service The 
Inquiry | radio programme 
(included as a good overview 
and a break from reading) 
19.08.2020 Continuing vital health services in Guinea-
Bissau during COVID-19 
UN Development Programme | 
Blog 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
21.08.2020 Advice on the use 
of masks for 
children in the 
community in the 
context of COVID-
19 
WHO | 
Overview 
 
• A Q&A on children and mass 
related to C19 
 03.08.2020 WHO COVID-19 
preparedness and 
response progress 
report – 1 February 
to 30 June 2020 
WHO | 
Report 
• This first report highlights the main 
points of progress that were made 
up to 30 June 2020 under the 3 
objectives outlined in the WHO 
C19 Strategic Response and 
Preparedness Plan published on 3 
Feb 2020 
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Dashboards & Trackers 
Cases & deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living evidence & 
policy maps 
Current research 
including trials 
  Diagnostics   Treatments   Vaccines 
WHO sitreps  WHO Africa  Ghana  COVID-NMA  WHO    FIND SARS-
CoV-2 Test 
Tracker 
  Global COVID-
19 Clinical Trial 
Tracker 
  CEPI 
WHO dashboard  African 
Arguments  
Indonesia  EPPI Centre  WHO International 
Clinical Trials 
Registry Platform 
(ICTRP)  
 FIND SARS-
CoV-2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre LSHTM  
Johns Hopkins 
University  
European 
CDC  
Nigeria CDC  Norwegian 
Institute of Public 
Health  
Cytel   Serology-based 
tests for COVID-
19 
  Solidarity trial  COVID-19 
Oxford 
Vaccine Trial 
WEF    Sierra Leone   Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH   Our World in 
Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
 COVID-19 
Vaccine 
Tracker 
Our World in 
Data  
  Singapore   Our World in 
Data: C19 Policy 
responses 
COVID-evidence        
Global 5050    UK   IFPRI COVID-19 
Policy Response 
Portal 
Cochrane        
CEBM, University 
of Oxford  
  US   COVID-19 
Primer 
Clinicaltrials.gov        
Humanitarian 
Data Exchange  
     NIH LitCovid  UKCDR       
Information is 
Beautiful  
     WHO COVID-19 
Database 
        
LSHTM                
HealthMap 
(cases) 
              
The Commons 
Project 
              
SeroTracker                
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y 
C19 Resource Hubs 
Global  Regional 
& Country 
Academic 
journals & 
Publishers 
Institutes/Centres/
Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa 
CDC 
Annals of 
Internal Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
BMJ LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Bulletin of the 
WHO 
ICL MRC Centre 
for Global 
Infectious Disease 
Analysis 
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, 
health 
systems & 
COVID-19 
UN African 
Academy 
of 
Sciences 
Cochrane  Center for Global 
Development 
 Epidemic 
Preparednes
s 
Innovations 
  Social 
Developm
ent Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and 
Eastern 
Africa 
COVID-19 
Digest 
Health Policy 
and Planning  
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Governme
nt 
JAMA Network Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   The Lancet  HEART     
UNESCO   medRxiv and 
bioRxiv 
(Preprints) 
 UKRI     
UN WFP   NEJM  Evidence Aid     
GOARN   Oxford University 
Press 
 NIH     
EPI-WIN   PLoS IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   SAGE journals  Prevent 
Epidemics  
    
Our World in 
Data 
  Science       
COVID-19 
Narratives by 
David 
Nabarro 
  Springer Nature       
Reliefweb   SSRN 
(Preprints)  
      
Humanitarian 
OpenStreetM
ap Team 
  Wiley       
Global 
Partnership 
for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 Diagnostics 
and Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid weekly search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary research 
papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease control 
and health system responses are included. Articles related to tackling the secondary impacts on other sectors are 
not included. Additional commentaries, opinions, and commissioned pieces are selected based on relevance. 
  
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report  
This weekly COVID-19 health evidence summary (HES) is based on 3.5 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before making 
decisions. The HES are not intended to replace medical or professional advice and the researcher or the K4D 
consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES alone. 
K4D services are provided by a consortium of leading organisations working in international development, led by 
the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds Nuffield 
Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), University of 
Birmingham International Development Department (IDD) and the University of Manchester Humanitarian and 
Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. It is 
licensed for non-commercial purposes only. K4D cannot be held responsible for errors, 
omissions or any consequences arising from the use of information contained in this health 
evidence summary. Any views and opinions expressed do not necessarily reflect those of 
DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020.               
 
 
